Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-phenyl-1H-pyrazole-3-carboxamide is a chemical compound belonging to the pyrazole-carboxamide class. While various derivatives of pyrazole-carboxamides have been investigated for diverse biological activities, including HDAC6 inhibition for acute liver injury, antidiabetic effects, and anticancer properties through DNA binding or kinase inhibition, specific drug-like properties, mechanisms of action, or therapeutic indications for the exact compound N-phenyl-1H-pyrazole-3-carboxamide are not clearly established in the available literature. It is classified as a pharmaceutical in some databases, suggesting its potential as a scaffold or a compound of interest in drug discovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-phenyl-1H-pyrazole-3-carboxamide.